FAIL (the browser should render some flash content, not this).
Publications by Dr. Cohen

Publications




PubMed links to other publications by Dr. Fred Cohen, PGS Founder



•   library
•   In the news

Publications:

Kumagai T, Ikezoe T, Gui D, O'Kelly J, Tong XJ, Cohen FJ, Said JW, Koeffler HP.

RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Clin Cancer Res. 2004 Feb 15;10(4):1508-20.

Dowsett M, Bundred NJ, Decensi A, Sainsbury RC, Lu Y, Hills MJ, Cohen FJ, Veronesi P, O'Brien ME, Scott T, Muchmore DB.

Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients.
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):961-6.

Johnston CC Jr, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath H 3rd, Gennari C, Christiansen C, Arnaud CD, Delmas PD.

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Arch Intern Med. 2000 Dec 11-25;160(22):3444-50.

Gradishar W, Glusman J, Lu Y, Vogel C, Cohen FJ, Sledge GW Jr.

Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
Cancer. 2000 May 1;88(9):2047-53.

Cohen FJ, Lu Y.

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials.
Maturitas. 2000 Jan 15;34(1):65-73.

Cohen FJ, Watts S, Shah A, Akers R, Plouffe L Jr.

Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60.
Obstet Gynecol. 2000 Jan;95(1):104-10.

de Valk-de Roo GW, Stehouwer CD, Meijer P, Mijatovic V, Kluft C, Kenemans P, Cohen F, Watts S, Netelenbos C.

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2993-3000.

Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR.

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA. 1999 Aug 18;282(7):637-45. Erratum in: JAMA 1999 Dec 8;282(22):2124.

 










Mitlak BH, Cohen FJ.

Selective estrogen receptor modulators: a look ahead.
Drugs. 1999 May;57(5):653-63.


Lee CY, Cohen FJ, Wu HB, Ooi GT, Rechler MM.

  

The absence of 150-kDa insulin-like growth factor complexes in fetal rat serum is not due to a lack of functional acid-labile subunit.
Horm Metab Res. 1999 Feb-Mar;31(2-3):182-5.


Cohen FJ, Eckert S, Mitlak BH.

  

Geographic differences in bone turnover: data from a multinational study in healthy postmenopausal women.
Calcif Tissue Int. 1998 Oct;63(4):277-82.


Mitlak BH, Cohen FJ.

  

In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators.
Horm Res. 1997;48(4):155-63.


Ooi GT, Cohen FJ, Tseng LY, Rechler MM, Boisclair YR.

Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver.
Mol Endocrinol. 1997 Jun;11(7):997-1007.


Ooi GT, Cohen FJ, Hsieh S, Seto D, Rechler MM, Boisclair YR.

Structure and regulation of the ALS gene.
Prog Growth Factor Res. 1995;6(2-4):151-7. Review.


Cohen FJ, Manni A, Glikman P, Bartholomew M, Demers L.

Interactions between growth factor secretion and polyamines in MCF-7 breast cancer cells.
Eur J Cancer. 1990;26(5):603-8.


Cohen FJ, Manni A, Glikman P, Bartholomew M, Demers L.

Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cancer Res. 1988 Dec 1;48(23):6819-25.